产品封面图

Y79

收藏
  • 询价
  • 2026年01月12日
    avatar
    15金牌会员
  • 企业认证

    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 年限

      2.5 years

    • 组织来源

      retina

    • 运输方式

      冻存运输

    • 细胞形态

      其他

    • 相关疾病

      其他疾病

    • 库存

      大量

    • ATCC Number

      HTB-18™

    • 生长状态

      悬浮生长

    • 器官来源

    • 物种来源

    • 是否是肿瘤细胞

      1

    Designations: Y79
    Depositors:  B Gallie
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: suspension
    Organism: Homo sapiens
    Morphology: multicellular clusters

    Source: Organ: eye
    Tissue: retina
    Disease: retinoblastoma
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Reverse Transcript: negative
    DNA Profile (STR): Amelogenin: X
    CSF1PO: 11,12
    D13S317: 11,12
    D16S539: 13,14
    D5S818: 11,12
    D7S820: 8,9
    THO1: 6,9.3
    TPOX: 8
    vWA: 15,18
    Cytogenetic Analysis: hypertriploidy, with abnormalities including dicentrics, breaks, pulverizations and minutes
    Isoenzymes: AK-1, 1
    ES-D, 1
    G6PD, B
    GLO-I, 2
    PGM1, 1
    Age: 2.5 years
    Gender: female
    Ethnicity: Caucasian
    Comments: The Y79 line was isolated by T.W. Reid and associates in January 1971 by explant culture of a primary tumor from the right eye obtained immediately after enucleation.
    The donor had a strong maternal family history of retinoblastoma.
    Ultrastructural features including nuclear membrane infoldings, triple membrane structures, microtubules, large coated vesicles, centrioles, basal bodies and annulate lamellae were reportedly similar to those of the original tumor.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 20%.
    Atmosphere: 5% CO2 in air recommended
    Temperature: 37.0°C
    Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:4 is recommended
    Medium Renewal: Twice per week
    Allow aggregates to settle to the bottom of the flask. Remove supernatant and discard. Add fresh medium, aspirate and dispense into new flasks.
    Preservation: Culture medium, 95%; DMSO, 5%
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
    recommended serum:ATCC 30-2020
    References: 22531: Reid TW, et al. Characteristics of an established cell line of retinoblastoma. J. Natl. Cancer Inst. 53: 347-360, 1974. PubMed: 4135597
    32287: Rostomily RC, et al. Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors. Cancer Res. 57: 3526-3531, 1997. PubMed: 9270024
    32684: Wong HK, Ziff EB. The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent trasactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity. J. Virol. 70: 332-340, 1996. PubMed: 8523545

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    • 凯基药物筛选中心细胞库目录

      胶质母细胞瘤细胞 U251   神经胶质瘤细胞 CRT   人神经胶质瘤细胞 Y79   人视网膜母细胞 白血病 JK(Jurkat)   人淋巴细胞瘤细胞 K562   人白血病细胞 937   人白血病细胞 NB4   人急性早幼粒白血病细胞肉瘤 05-732   人骨肉瘤细胞 HT1080   人纤维肉瘤细胞 黑色素瘤 MV3   人黑色素瘤细胞 M14   人黑色素瘤细胞 正常细胞 VE   人血管内皮细胞 EC-304   人血管内皮细胞 HELF   人胚肺成纤维细胞 L-

    • Characterization of Adrenoceptors

      α 2C Opossum kidney, human caudate nucleus OK cells, Y79 cells, transfected cells

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1620
    博辉生物科技(广州)有限公司
    2025年11月20日询价
    ¥1980
    上海酶研生物科技有限公司
    2025年07月25日询价
    ¥1280
    上海康朗生物科技有限公司
    2026年01月08日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月12日询价
    ¥2200
    上海钰博生物科技有限公司
    2025年07月15日询价
    Y79
    询价